Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector
查看参考文献14篇
文摘
|
AIM: To establish a high pressure liquid chromatography (HPLC) method for determination of the concentration of gemcitabine (dFdC) and its metabolite (dFdU) in human plasma. METHODS: Plasma 1.0 mL spiked with floxuridine as an internal standard was extracted with 3.0 mL of methanol-acetonitrile (v/v, 1:9). The supernatant was evaporated at 60 oC and the residue was reconstituted with 0.5 mL of the solution used as the mobile phase. After centrifugation, 50 μL of the supernatant was injected into the HPLC system. Separation was achieved on a C18 (4.6 mm×250 mm, 5 μm) column at 25 oC with the flow rate of the mobile phase set to 0.8 mL/min. The compounds were detected at 268 nm. The mobile phase consisted of 40.0 mmol/L acetate ammonium buffer solution (pH 5.5) and acetonitrile (v/v, 97.5:2.5). RESULTS: The linear range was 0.20-10.0 mg/L (r=0.9999) for dFdC and 0.50-50.0 mg/L (r=0.9999) for dFdU. The limit of detection (LOD) was 0.10 mg/L for dFdC and 0.25 mg/L for dFdU, while the limit of quantification (LOQ) was 0.20 mg/L (RSD<10 %) for dFdC and 0.50 mg/L (RSD<3 %) for dFdU. The average recovery of dFdC and dFdU by this method were 103.3 % and 98.7 %, respectively. For intra-day and inter-day, the corresponding standard deviations of the measurements of dFdC and dFdU were both less than 5.5 %. CONCLUSION: An analytical method was established to measure the concentrations of dFdC and dFdU in human plasma and was effectively applied to the dFdC and dFdU pharmacokinetic studies of 8 Chinese patients with malignant tumors. |
来源
|
Acta Pharmacologica Sinica
,2004,25(12):1584-1589 【核心库】
|
关键词
|
high pressure liquid chromatography
;
gemcitabine
;
deoxycytidine
;
floxuridine
|
地址
|
1.
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310031
2.
Zhejiang Cancer Hospital, Hangzhou, 310022
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
1671-4083 |
学科
|
药学 |
基金
|
浙江省教育厅项目
|
文献收藏号
|
CSCD:1841668
|
参考文献 共
14
共1页
|
1.
Kosmas C. An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small-cell lung cancer.
Crit Rew Oncol Hematol,2003,45:265-275
|
CSCD被引
4
次
|
|
|
|
2.
Heinemann V. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Oncology,2003,64:191-206
|
CSCD被引
6
次
|
|
|
|
3.
Moore M J. a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
J Clin Oncol,2003,27:3296-3302
|
CSCD被引
12
次
|
|
|
|
4.
Shipley L A. an oncolytic deoxycytidine analog in mice.
Drug Metab Dispos,1992,20:849-855
|
CSCD被引
4
次
|
|
|
|
5.
Abbruzzese J L. plasma and cellular pharmacology study of gemcitabine.
J Clin Oncol,1991,9:491-498
|
CSCD被引
9
次
|
|
|
|
6.
Edzes H T. Determination of the antimetabolite gemcitabine (2′.
Anal Biochem,1993,214:25-30
|
CSCD被引
1
次
|
|
|
|
7.
Sottani C. Validated procedure for simultaneous trace level determination of the anti-cancer agent gemcitabine and its metabolite in human urine by high-performance liquid chromatography with tandem mass spectrometry.
Rapid Commun Mass Spectrom,2004,18:1017-1023
|
CSCD被引
1
次
|
|
|
|
8.
Yilmaz B. Comparison of zero- and second-order derivative spectrophotometric and HPLC methods for the determination of gemcitabine in human plasma.
Farmaco,2004,59:425-429
|
CSCD被引
1
次
|
|
|
|
9.
Wang L Z. An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.
Ther Drug Monit,2003,25:552-557
|
CSCD被引
5
次
|
|
|
|
10.
Kerr J Z. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.
Cancer Chemother Pharmacol,2001,47:411-414
|
CSCD被引
5
次
|
|
|
|
11.
Freeman K B. Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection.
J Chromatogr B Biomed Appl,1995,665:171-181
|
CSCD被引
1
次
|
|
|
|
12.
Decosterd L A. Simultaneous determination of deoxyribonucleoside in the presence of ribonucleoside tri-phosphates in human carcinoma cells by high-performance liquid chromatography.
Anal Biochem,1999,270:59-68
|
CSCD被引
2
次
|
|
|
|
13.
Yilmaz B. Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.
J Chromatogr B Analyt Technol Biomed Life Sci,2003,791:103-109
|
CSCD被引
1
次
|
|
|
|
14.
Kiani A. effective clearance of its main metabolite by standard hemodialysis treatment.
Cancer Chemother Pharmacol,2003,51:266-270
|
CSCD被引
8
次
|
|
|
|
|